Back

Integrated care improves outcomes in multimorbid patients with atrial fibrillation: insights from the MIRACLE-AF trial

30 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Epidemiology, prognosis, and outcomes in atrial fibrillation Clinical ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Ming Fang Li

The First Affiliated Hospital of Nanjing Medical University, Nanjing (China)

6 More presentations in this session

Presentation thumbnail
Association between biological aging acceleration and adverse cardiovascular prognosis in atrial fibrillation patients: a multicenter real-world cohort study
Professor T. Liu (Tianjin, CN)
Abstract
Presentation thumbnail
Renal function and outcomes in subclinical atrial fibrillation: a prespecified analysis of the ARTESIA trial
Doctor R. Reddy (Durham, US)
Abstract
Presentation thumbnail
Predictions of adverse outcomes using different renal function estimation formulas in patients with atrial fibrillation receiving direct oral anticoagulants
Doctor T. Chao (Taipei, TW)
Abstract
Presentation thumbnail
Primary care physician continuity improve survival in patients with atrial fibrillation: a retrospective analysis of 15,000 patients with atrial fibrillation
Professor J. Gonzalez Juanatey (Santiago de Compostela, ES)
Abstract
Presentation thumbnail
Early electrical cardioversion for early recurrent atrial tachyarrhythmia after pulmonary vein isolation in atrial fibrillation: a global real-world analysis
Miss L. Serio (L'Aquila, IT)
Abstract

Access the full session

Session thumbnail
Epidemiology, prognosis, and outcomes in atrial fibrillation

The Event

Event poster

ESC Congress 2026

30 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
MIRACLE-AF - A Novel Model of IntegRAted Care of OLdEr Patients with Atrial Fibrillation in rural China
1 September 2024
thumbnail
Congress Presentation
The importance of multimorbidity for adherence to therapeutic recommendations in patients with heart failure who receive continuity of care after hospital discharge.
20 May 2023
thumbnail
Congress Presentation
Bleeding risks with frailty and multimorbidity in patients with atrial fibrillation. A nationwide analysis of 1.4 million subjects
31 August 2020
thumbnail
Congress Presentation
The role of the novel MyAlgos e-medicine Platform in promoting patient-centered self-care management in patients with atrial fibrillation: The emPOWERD trial
15 April 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources